CLOZAPINE Response in Biotype-1
Conditions
Schizophrenia · Schizoaffective Disorder · Bipolar 1 Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hartford Healthcare, Hartford, Connecticut, United States
University of Georgia, Athens, Georgia, United States
University of Chicago, Chicago, Illinois, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
UT Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Yelonda Williams, B.A) · yelonda.williams@utsouthwestern.edu · 214/645-2784
Study leads
Carol Tamminga, M.D.
Principal Investigator
University of Texas Southwestern Medical Center